Impact of asthma therapy on cardiovascular disorders in the elderly

Immunology and Allergy Clinics of North America

Volumn 17, Issue 4, 1997, Pages 627-644

  Vossler, Mark R ^a   Kron, Jack ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001659006     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70334-9     Document Type: Article

References (95)

1. Barnes PJ: Inhaled glucocorticoids for asthma. N Engl J Med 332:868-875, 1995
2. Bertolet BD, Murtrie EBM, Hill JA, et al: Theophylline for the treatment of atrioventricular block after myocardial infarction. Ann Intern Med 123:509-511, 1995
3. Berul CI, Morad M: Regulation of potassium channels by nonsedating antihistamines. Circulation 91:2220-2225, 1995
4. Beta-Blocker Heart Attack Trial Research Group: A randomized trial of propranolol in patients with acute myocardial infarction. JAMA (247)1707-1714, 1982
5. Blouin RA, Erwin WG, Foster TS: Pharmacokinetics of theophylline in young and elderly subjects. Gerontology 28:323-327, 1981
6. Braman S: Asthma in the elderly patient. Clin Chest Med 14:413-422, 1993
7. Brannan M, Reidenberg P, Radwanski E, et al: Loratadine administered concomitantly with erythromycin: Pharmacokinetic and electrocardiographic evaluations. Clin Pharmacol Ther 58:269-278, 1995
8. Brodde O: Beta-adrenoceptors in cardiac disease. Pharmacol Ther 60:405-430, 1994
9. Brown JH, Taylor P: Muscarinic receptor agonists and antagonists. In Hardman JG, Limbird LE (eds): Goodman and Gilman's The Pharmacologic Basis of Therapeutics. New York, McGraw-Hill, 1996, pp 141-160
10. Chandler MHH, Clifton GD, Burki NK: Pulmonary function in the elderly: Response to theophylline bronchodilation. J Clin Pharmacol 30:330-335, 1990
11. Connolly MJ: Aging, late-onset asthma and the beta-adrenoceptor. Pharmacol Ther 60:389-404, 1994
12. Cosgriff WW: Thromboembolic complications associated with ACTH and cortisone therapy. JAMA 147:924-926, 1951
13. Daley PJ, Mahn TH, Zielonka JS, et al: Effect of maintenance oral theophylline on dipyridamole-thallium-201 myocardial imaging using SPECT and dipyridamole-induced hemodynamic changes. Am Heart J 115:1185-1192, 1988
14. Danish Study Group on Verapamil in Myocardial Infarction: Effects of Verapamil on mortality and major events after myocardial infarction. Am J Cardiol 66:779-785, 1990
15. Deckers W: The chemistry of new derivatives of tropane alkaloids and the pharmacokinetics of a new quaternary compound. Postgrad Med J 51:76-81, 1975
16. Deedwania PC: Prevalence and prognosis of heart failure. Cardiology Clinics 12:1-8, 1994
17. Degroff CG, Silka MJ: Bronchospasm after intravenous administration of adenosine in a patient with asthma. J Pediatr 125:822-823, 1994
18. Dodge RR, Burrows B: The prevalence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 122:567-575, 1980
19. Duncan AK, Vittone J, Fleming KC, et al: Cardiovascular disease in elderly patients. Mayo Clin Proc 71:184-196, 1996
20. Ekelund LG, Holmgren A: Central hemodynamics during exercise. Circ Res 20(suppl):33-43, 1967
21. Fahy JV, Boushey HA: Controversies involving inhaled beta-agonists and inhaled corticosteroids in the treatment of asthma. Clin Chest Med 16:715-733, 1995
22. Ferry DR, Henry RL, Kern MJ: Epinephrine-induced myocardial infarction in a patient with angiographically normal coronary arteries. Am Heart J 111:1193-1195, 1986
23. Gaudreault P, Guay J: Theophylline poisoning: Pharmacologic considerations and clinical management. Med Toxicol 1:169, 1986
24. Ghali JK, Cooper R, Ford E: Trends in hospitalization rates for heart failure in the United States 1973-1986: Evidence for increasing population prevalence. Arch Intern Med 150:769-773, 1990
25. Godden DJ, Seymor DNA, Robertson DA: 75 deaths in asthmatics prescribed home nebulisers. BMJ 294:1356, 1987
26. Gross NJ: Ipratropium bromide. N Engl J Med 319:486-494, 1988
27. Hammerman H, Kloner RA, Hale S, et al: Dose dependent effects of short-term methylprednisolone on myocardial infarct extension, scar formation, and ventricular function. Circulation 68:446-453, 1983
28. Hennenkens CH, Albert CM, Godfried SL, et al: Adjunctive drug therapy of acute myocardial infarction - evidence from clinical trials. N Engl J Med 335:1660-1667, 1996
29. Hennenkens CH, Buring JE: Aspirin in the primary prevention of cardiovascular disease. Cardiol Clin 12:443-450, 1994
30. Hershberger RE: Beta-adrenergic receptor agonists and antagonists in heart failure. In Hosenpud JD, Greenberg BH (eds): Congestive Heart Failure. New York, Springer-Verlag, 1994, pp 454-494
31. Hoffman BB, Lefkowitz RJ: Catecholamines, sympathomimetic drugs and adrenergic receptor antagonists. In Hardman JG, Limbrid LE (eds): Goodman and Gilman's The Pharmacologic Basis of Therapeutics. New York, McGraw-Hill, 1996, pp 199-247
32. Homoud M, Foote CB, NAME III, et al: Atrioventricular junctional ablation and modification for atrial fibrillation. Cardiol Clin 14:555-567, 1996
33. Honig PK, Woolsey RL, Samani K, et al: Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 52:231-238, 1992
34. Honig PK, Wortham DC, Zamani K, et al: Terfenadine-ketoconazole interaction: Pharmokinetic and electrocardiographic consequences. JAMA 269:1513-1518, 1993
35. Hope JA: Treatise on Diseases of the Heart and Great Vessels. London, Williams Kid, 1833
36. Ip M, Lam K, Yarn L, et al: Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 105:1722-1727, 1994
37. ISIS-1 Collaborative Group: Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2:57-66, 1986
38. ISIS-2 Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,1787 cases of suspected acute myocardial infarction. Lancet 1:203, 1988
39. ISIS-4 Collaborative Group: ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345:669-685, 1995
40. Javaheri S, Parker TJ, Wexler L, et al: Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 335:562-567, 1996
41. Jeejeebhoy KN, Bruce-Robertson A, Ho J, et al: The effect of cortisol on the synthesis of plasma albumin fibrinogen and transferrin. Biochem J 130:533-538, 1972
42. Jonsson H, Nived O, Sturfelt G: Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population. Medicine 68:141-150, 1989
43. Josephson GW, Kennedy HL, Mackenzie EJ: Cardiac dysrhythmias during the treatment of acute asthma. A comparison of two treatment regimens by a double blind protocol. Chest 78:429-435, 1980
44. Kannel WB, Plehu JF, Cupples LA: Cardiac failure and sudden death in Framingham study. Am Heart J 115:869-875, 1988
45. Lakata EG, Gerstenblith G, Weisfeldt ML: The aging heart: Structure, function and disease. In Braunwald E (ed): Heart Disease, a Textbook of Cardiovascular Medicine. Philadelphia, WB Saunders, 1996, pp 1687-1703
46. Langberg JJ, Chin M, Schamp DJ, et al: Ablation of the atrioventricular junction with radiofrequency energy using a new electrode catheter. Am J Cardiol 67:142-147, 1991
47. Lin C, Chuan I, Cheng KK, et al: Arrhythmogenic effects of theophylline in human atrial tissue. Int J Cardiol 17:289-297, 1987
48. Lipworth BJ: Clinical pharmacology of corticosteroids in patients with bronchial asthma. Pharmacol Ther 58:173-209, 1993
49. Lorell BH, Grossman W: Dynamic and isometric exercise during cardiac catheterization. In Grossman W, Baim D (eds): Cardiac Catheterization, Angiography and Intervention, ed 4. Philadelphia, Lea and Febiger, 1991, pp 267-282
50. Mahmarian JJ, Verani MS: Myocardial perfusion imaging during pharmacologic stress testing. Cardiol Clin 12:223-246, 1994
51. Maxwell SRJ, Moots RJ, Kendall MJ: Corticosteroids: Do they damage the cardiovascular system? Postgrad Med J 70:863-870, 1994
52. Zafirlukast for asthma. Med Lett Drugs Ther 38:111-112, 1996
53. Mohrman DE, Feigl EO: Competition between sympathetic vasoconstriction and metabolic vasodilatation in the canine coronary circulation. Circ Res 42:79-86, 1978
54. Multicenter Diltiazem Postinfarction Trial Research Group: The effects of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 319:385-392, 1988
55. Nashel DJ: Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 80:925-929, 1986
56. Nelson HS: Beta-adrenergic bronchodilators. N Engl J Med 333:499-506, 1995
57. Osler W: Lectures on Angina Pectoris and Allied States. New York, Appleton, 1897
58. Packer M, Bristow MR, Cohn JN, et al: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349-1355, 1996
59. Page R, Gay W, Friday G, et al: Isoproterenol-associated myocardial dysfunction during status asthmaticus. Ann Allergy 57:402-404, 429-430, 1986
60. Pearce N, Beasley R, Crane J, et al: End of the New Zealand asthma mortality epidemic. Lancet 345:41-44, 1995
61. Pfeffer MA, Braunwald E, Moye LA, et al: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 327:678-684, 1992
62. Ramsdell J: Use of theophylline in the treatment of COPD. Chest (suppl)107(5):206S-209S, 1995
63. Robin ED, McCauley R: Sudden cardiac death in bronchial asthma, and inhaled beta-adrenergic agonists. Chest 101:1699-1702, 1992
64. Sakai K, Hosoda S, Shimamoto K: Late rupture of left ventricular true aneurysm after acute myocardial infarction. Clin Cardiol 16:573-575, 1993
65. Sale ME, Barbey JT, Woolsey RL, et al: The electrocardiographic effects of cetirizine in normal subjects. Clin Pharmacol Ther 56:295-301, 1994
66. Schimmer BP, Parker KL: Adrenocorticotropic hormone: Adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In Hardman JG, Limbird LE (eds): Goodman and Gilman's The Pharmacologic Basis of Therapeutics. New York, McGraw-Hill, 1996, pp 1459-1485
67. Serafin WE: Drugs used in the treatment of asthma. In Hardman JG, Limbird LE (eds): Goodman and Gilman's The Pharmacologic Basis of Therapeutics. New York, McGraw-Hill, 1996, pp 659-682
68. Settipane GA, Klein DE, Boyd GK, et al: Adverse reactions to cromolyn. JAMA 23:811-815, 1979
69. Shannon M, Lovejoy FH: The influence of age vs peak serum concentration on life-threatening events after chronic theophylline intoxication. Arch Intern Med 150:2045-2048, 1990
70. Shapiro GG, Konig P: Cromolyn sodium: A review. Pharmacotherapy 5:156-170, 1985
71. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the elderly program. JAMA 265:3255-3260, 1991
72. Silverman HS, Pfeifer MP: Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction. Am J Cardiol 59:363-364, 1987
73. Sitar DS, Aoki FY, Warren CP, et al: A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma. Chest 103:771-776, 1993
74. Sly RM, Anderson JA, Bierman CW, et al: Position Statement: Adverse effects and complications of treatment with beta-adrenergic agonist drugs. J Allergy Clin Immunol 75:443-449, 1985
75. Smith LJ: Leukotrienes in asthma. Arch Intern Med 156:2181-2189, 1996
76. SOLVD Investigators: The effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685-691, 1992
77. SOLVD Investigators: The effect of enalapril on survival in patients with reduced ejection fractions and congestive heart failure. N Engl J Med 325:293-301, 1991
78. Soumerai SB, McLaughlin TJ, Spiegelman D, et al: Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 277:115-121, 1997
79. Spector S, Hendeles L, Szefler SJ: A report from the workshop on pharmacology. J Allergy Clin Immunol 80:440, 1987
80. Spector SL, Smith LJ, Glass M: Effects of six weeks of therapy with oral doses of ICI 204,210, a leukotriene D4 receptor antagonist in subjects with bronchial asthma. Am J Respir Crit Care Med 150:618-623, 1994
81. Spitzer WO, Suissa S, Ernst P, et al: The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 326:501-506, 1992
82. Starke ID, Luce P: The Efficacy and Safety of Inhaled Salmeterol 50mcg bd in older patients with reversible airflow obstruction. Age Ageing 25:67-71, 1996
83. Straat E, Edlund A, Henriksson P: Improved working capacity in patients with ischemic heart disease during a 10-day treatment with oral theophylline. J Intern Med 232:53-58, 1992
84. SPAF Investigators: Stroke prevention in atrial fibrillation study: Final results. Circulation 84:527-539, 1991
85. Suissa S, Ernst P, Boivin J-F, et al: A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 149:604-610, 1994
86. Ullah MI, Newman GB, Saunders KB: Influence of age on response to ipratroprium bromide and salbutamol in asthma. Thorax 36:523-529, 1981
87. Uren NG, Davies SW, Jordan SL, et al: Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failure. Eur Heart J 14:744-750, 1993
88. Vantrimpont P, Roleau JL, Wun CC, et al: Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the survival and ventricular enlargement (SAVE) study. J Am Coll Cardiol 29:229-236, 1997
89. Vestal RE, Cusack BJ, Mercer GD: Aging and drug interactions: Effects of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men. J Pharmacol Exp Ther 241:588-600, 1987
90. Windom HH, Burgess CD, Siebers RWL, et al: The pulmonary and extrapulmonary effects of inhaled B-agonists in patients with asthma. Clin Pharmacol Ther 48:296-301, 1990
91. Wolf PA, Abbot RD: Atrial fibrillation as an independent risk factor for stroke: The Framingham study. Stroke 22:983-988, 1991
92. Wong CS, Pavord ID, Williams J, et al: Bronchodilator, cardiovascular and hypokalemic effects of fenoterol, salbutamrol, and terbutaline in asthma. Lancet 336:1396-1399, 1990
93. Woolsley RL: Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol 36:233-252, 1996
94. Woosley RL, Chen Y, Freiman JP, et al: Mechanism of the cardiotoxic actions of terfenadine. JAMA 269:1532-1536, 1993
95. Ziment I: Infrequent cardiac deaths occur in bronchial asthma. Chest 101:1703-1705, 1992